XML 114 R27.htm IDEA: XBRL DOCUMENT v3.19.3
Capitalization And Short-Term Borrowings (Tables)
12 Months Ended
Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary Of Changes In Common Stock Equity
Summary of Changes in Common Stock Equity
 
Common Stock
 
Paid In
Capital
 
Earnings
Reinvested
in the
Business
 
Accumulated
Other
Comprehensive
Income (Loss)
Shares
 
Amount
 
 
(Thousands, except per share amounts)
Balance at September 30, 2016
85,119

 
$
85,119

 
$
771,164

 
$
676,361

 
$
(5,640
)
Net Income Available for Common Stock
 
 
 
 
 
 
283,482

 
 
Dividends Declared on Common Stock ($1.64 Per Share)
 
 
 
 
 
 
(140,090
)
 
 
Cumulative Effect of Adoption of Authoritative Guidance for Stock-Based Compensation
 
 
 
 
 
 
31,916

 
 
Other Comprehensive Loss, Net of Tax
 
 
 
 
 
 
 
 
(24,483
)
Share-Based Payment Expense(1)
 
 
 
 
10,902

 
 
 
 
Common Stock Issued Under Stock and Benefit Plans
424

 
424

 
14,580

 
 
 
 
Balance at September 30, 2017
85,543

 
85,543

 
796,646

 
851,669

 
(30,123
)
Net Income Available for Common Stock
 
 
 
 
 
 
391,521

 
 
Dividends Declared on Common Stock ($1.68 Per Share)
 
 
 
 
 
 
(144,290
)
 
 
Other Comprehensive Loss, Net of Tax
 
 
 
 


 
 
 
(37,627
)
Share-Based Payment Expense(1)


 


 
14,235

 
 
 
 
Common Stock Issued Under Stock and Benefit Plans
414

 
414

 
9,342

 


 


Balance at September 30, 2018
85,957

 
85,957

 
820,223

 
1,098,900

 
(67,750
)
Net Income Available for Common Stock
 
 
 
 
 
 
304,290

 
 
Dividends Declared on Common Stock ($1.72 Per Share)
 
 
 
 
 
 
(148,432
)
 
 
Cumulative Effect of Adoption of Authoritative Guidance for Financial Assets and Liabilities
 
 
 
 
 
 
7,437

 
 
Cumulative Effect of Adoption of Authoritative Guidance for Reclassification of Stranded Tax Effects
 
 
 
 
 
 
10,406

 
 
Other Comprehensive Income, Net of Tax
 
 
 
 
 
 
 
 
15,595

Share-Based Payment Expense(1)
 
 
 
 
19,613

 
 
 
 
Common Stock Issued (Repurchased) Under Stock and Benefit Plans
358

 
358

 
(7,572
)
 
 
 
 
Balance at September 30, 2019
86,315

 
$
86,315

 
$
832,264

 
$
1,272,601

(2)
$
(52,155
)
 
(1)
Paid in Capital includes compensation costs associated with SARs, performance shares and/or restricted stock awards. The expense is included within Net Income Available for Common Stock, net of tax benefits.
(2)
The availability of consolidated earnings reinvested in the business for dividends payable in cash is limited under terms of the indentures covering long-term debt. At September 30, 2019, $1.1 billion of accumulated earnings was free of such limitations.
Schedule Of Share-Based Compensation For SARs
Transactions for 2019 involving SARs for all plans are summarized as follows:
 
Number of
Shares Subject
To Option
 
Weighted
Average
Exercise Price
 
Weighted
Average
Remaining
Contractual
Life (Years)
 
Aggregate
Intrinsic
Value
(In thousands)
Outstanding at September 30, 2018
1,299,088

 
$
50.70

 
 
 
 
Granted in 2019

 
$

 
 
 
 
Exercised in 2019
(528,456
)
 
$
43.94

 
 
 
 
Forfeited in 2019

 
$

 
 
 
 
Expired in 2019
(37,500
)
 
$
63.87

 
 
 
 
Outstanding at September 30, 2019
733,132

 
$
54.90

 
1.73
 
$

SARs exercisable at September 30, 2019
733,132

 
$
54.90

 
1.73
 
$

Shares available for future grant at September 30, 2019(1)
1,225,831

 
 
 
 
 
 
 

(1)
Includes shares available for options, SARs, restricted stock and performance share grants.
Schedule Of Share-Based Compensation For Restricted Share Awards
Transactions for 2019 involving restricted share awards for all plans are summarized as follows: 
 
Number of
Restricted
Share Awards
 
Weighted Average
Fair Value per
Award
Outstanding at September 30, 2018
20,000

 
$
47.46

Granted in 2019

 
$

Vested in 2019

 
$

Forfeited in 2019

 
$

Outstanding at September 30, 2019
20,000

 
$
47.46


Schedule Of Share-Based Compensation For Non-Performance Based Restricted Stock Units
Transactions for 2019 involving nonperformance-based restricted stock units for all plans are summarized as follows:
 
Number of
Restricted
Stock Units
 
Weighted Average
Fair Value per
Award
Outstanding at September 30, 2018
245,316

 
$
48.45

Granted in 2019
123,939

 
$
49.40

Vested in 2019
(80,354
)
 
$
48.24

Forfeited in 2019
(7,294
)
 
$
50.40

Outstanding at September 30, 2019
281,607

 
$
48.88


Schedule of Share-based Compensation for Performance Shares
Transactions for 2019 involving performance shares for all plans are summarized as follows:
 
Number of
Performance
Shares
 
Weighted Average
Fair Value per
Award
Outstanding at September 30, 2018
641,290

 
$
44.49

Granted in 2019
244,734

 
$
55.67

Vested in 2019
(281,882
)
 
$
31.16

Forfeited in 2019
(109,806
)
 
$
54.19

Change in Units Based on Performance Achieved
28,178

 
$
35.14

Outstanding at September 30, 2019
522,514

 
$
54.37


Schedule Of Long-Term Debt
The outstanding long-term debt is as follows:
 
At September 30
 
2019
 
2018
 
(Thousands)
Medium-Term Notes(1):
 
 
 
7.4% due March 2023 to June 2025
$
99,000

 
$
99,000

Notes(1)(2)(3):
 
 
 
3.75% to 5.20% due December 2021 to September 2028
2,050,000

 
2,050,000

Total Long-Term Debt
2,149,000

 
2,149,000

Less Unamortized Discount and Debt Issuance Costs
15,282

 
17,635

Less Current Portion(4)

 

 
$
2,133,718

 
$
2,131,365

 
(1)
The Medium-Term Notes and Notes are unsecured.
(2)
The holders of these notes may require the Company to repurchase their notes at a price equal to 101% of the principal amount in the event of both a change in control and a ratings downgrade to a rating below investment grade.
(3)
The interest rate payable on $300.0 million of 4.75% notes and $300.0 million of 3.95% notes will be subject to adjustment from time to time, with a maximum of 2.00%, if certain change of control events involving a material subsidiary result in a downgrade of the credit rating assigned to the notes to below investment grade (or if the credit rating assigned to the notes is subsequently upgraded).
(4)
None of the Company's long-term debt at September 30, 2019 and 2018 will mature within the following twelve-month period.
Performance Shares [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Weighted Average Assumptions Used in Estimating Fair Value The following assumptions were used in estimating the fair value of the TSR performance shares at the date of grant:
 
Year Ended September 30
 
2019
 
2018
 
2017
Risk-Free Interest Rate
2.61
%
 
1.96
%
 
1.54
%
Remaining Term at Date of Grant (Years)
2.78

 
2.78

 
2.79

Expected Volatility
20.2
%
 
22.0
%
 
22.6
%
Expected Dividend Yield (Quarterly)
N/A

 
N/A

 
N/A